Management of Visual Dysfunction in Patients with Parkinson's Disease

J Parkinsons Dis. 2020;10(s1):S49-S56. doi: 10.3233/JPD-202103.

Abstract

Parkinson's disease (PD) is a movement disorder with many symptoms responsive to treatment with dopamine agonists, anti-cholinergics and the dopamine precursor, levodopa. The cardinal features of PD include tremor, rigidity, bradykinesia, and postural instability. There also are non-motor features that include sleep disorders, cognitive and affective dysfunction, hyposmia, pain and dysautonomia (constipation, bloating, orthostasis, urinary symptoms, sexual dysfunction, dysphagia). Among these non-motor features are signs and symptoms of visual system impairment that range from subtle examination findings to those causing severe disability. In this review we describe common PD-related abnormalities in the visual system, how they present, and potential treatments.

Keywords: Parkinson’s disease; diplopia; dry eye; hallucination; vision.

Publication types

  • Review

MeSH terms

  • Disease Management*
  • Dopamine Agonists / therapeutic use
  • Hallucinations / etiology
  • Hallucinations / physiopathology
  • Hallucinations / therapy
  • Humans
  • Oculomotor Nerve Diseases / etiology
  • Oculomotor Nerve Diseases / physiopathology
  • Oculomotor Nerve Diseases / therapy
  • Parkinson Disease / complications*
  • Parkinson Disease / physiopathology
  • Parkinson Disease / therapy*
  • Retinal Diseases / etiology
  • Retinal Diseases / physiopathology
  • Retinal Diseases / therapy
  • Vision Disorders / etiology*
  • Vision Disorders / physiopathology
  • Vision Disorders / therapy*

Substances

  • Dopamine Agonists